Literature DB >> 23415512

Prevalence of migraine and Raynaud phenomenon in women with apical ballooning syndrome (Takotsubo or stress cardiomyopathy).

Dawn C Scantlebury1, Abhiram Prasad, Alejandro A Rabinstein, Patricia J M Best.   

Abstract

Apical ballooning syndrome (ABS), migraine, and Raynaud phenomenon are characterized by female predominance, identifiable triggers, and, likely, vascular dysfunction. Estrogen deficiency, such as in menopause, is considered to be a predisposing factor for ABS. We investigated the association of ABS with migraine, Raynaud phenomenon, and hormonal factors. We compared 25 consecutive residents (all women) of Olmsted County, Minnesota, presenting with ABS, to 2 age-matched control groups from the same community: 25 women presenting with ST-segment elevation myocardial infarction (STEMI), matched for the index ABS event date, and 50 women with neither diagnosis. The patients with ABS were more likely to have a migraine history (11 [44%] vs 4 [16%] STEMI controls, p = 0.031, and vs 6 [12%] population controls, p = 0.003), and "possible migraine" (including other headache syndromes suggestive of migraine; 15 [60%] vs 6 [24%] STEMI controls, p = 0.012; and vs 12 [24%] population controls, p = 0.003). Of the patients with ABS, 4 (16%) had Raynaud phenomenon compared to no STEMI controls and 1 (2%) population control (p = 0.038). No differences were present in parity, menopausal status, years since the onset of menopause, and frequency of oophorectomy. Current hormonal replacement therapy use was greater in those with ABS than in the population controls: 4 (16%) versus none (p = 0.002). In conclusion, the association of ABS with migraine and Raynaud phenomenon supports a role of vasomotor dysfunction in the pathogenesis of ABS. The absence of an association with reproductive characteristics and the finding that ABS occurred despite exogenous hormonal use in some patients suggests that estrogen deficiency per se is not the primary factor in the pathophysiology.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23415512     DOI: 10.1016/j.amjcard.2013.01.269

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

1.  Understanding the pathophysiology of apical ballooning syndrome: a step closer.

Authors:  Jaya Bathina; Sandra Weiss; William S Weintraub
Journal:  Expert Rev Cardiovasc Ther       Date:  2014-12-09

2.  Stress-coping skills and neuroticism in apical ballooning syndrome (Takotsubo/stress cardiomyopathy).

Authors:  Dawn C Scantlebury; Daniel E Rohe; Patricia J M Best; Ryan J Lennon; Amir Lerman; Abhiram Prasad
Journal:  Open Heart       Date:  2016-02-05

3.  International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology.

Authors:  Jelena-Rima Ghadri; Ilan Shor Wittstein; Abhiram Prasad; Scott Sharkey; Keigo Dote; Yoshihiro John Akashi; Victoria Lucia Cammann; Filippo Crea; Leonarda Galiuto; Walter Desmet; Tetsuro Yoshida; Roberto Manfredini; Ingo Eitel; Masami Kosuge; Holger M Nef; Abhishek Deshmukh; Amir Lerman; Eduardo Bossone; Rodolfo Citro; Takashi Ueyama; Domenico Corrado; Satoshi Kurisu; Frank Ruschitzka; David Winchester; Alexander R Lyon; Elmir Omerovic; Jeroen J Bax; Patrick Meimoun; Guiseppe Tarantini; Charanjit Rihal; Shams Y-Hassan; Federico Migliore; John D Horowitz; Hiroaki Shimokawa; Thomas Felix Lüscher; Christian Templin
Journal:  Eur Heart J       Date:  2018-06-07       Impact factor: 29.983

Review 4.  Takotsubo Cardiomyopathy: Understanding the Pathophysiology of Selective Left Ventricular Involvement.

Authors:  Deepak Kumar Pasupula; Venkata Suresh Patthipati; Awais Javed; Sudeep K Siddappa Malleshappa
Journal:  Cureus       Date:  2019-10-23

Review 5.  Current Knowledge and Future Challenges in Takotsubo Syndrome: Part 1-Pathophysiology and Diagnosis.

Authors:  Elias Rawish; Thomas Stiermaier; Francesco Santoro; Natale D Brunetti; Ingo Eitel
Journal:  J Clin Med       Date:  2021-01-28       Impact factor: 4.241

6.  Evaluation of the Safety of Calcitonin Gene-Related Peptide Antagonists for Migraine Treatment Among Adults With Raynaud Phenomenon.

Authors:  Ilana D Breen; Caitlin M Brumfiel; Meera H Patel; Richard J Butterfield; Juliana H VanderPluym; Leroy Griffing; Mark R Pittelkow; Aaron R Mangold
Journal:  JAMA Netw Open       Date:  2021-04-01

7.  Reproductive History in Takotsubo Syndrome, A Register-Based Cohort Study.

Authors:  Tornvall Per; Järnbert Pettersson Hans
Journal:  Front Cardiovasc Med       Date:  2021-09-06

Review 8.  Update of Takotsubo cardiomyopathy: Present experience and outlook for the future.

Authors:  Anastasiia V Bairashevskaia; Sofiya Y Belogubova; Mikhail R Kondratiuk; Daria S Rudnova; Susanna S Sologova; Olga I Tereshkina; Esma I Avakyan
Journal:  Int J Cardiol Heart Vasc       Date:  2022-03-07

9.  Case Report: Steroid-Responsive Takotsubo Cardiomyopathy Associated With Cytokine Storm and Obstructive Shock.

Authors:  Brent Gudenkauf; Michael R Goetsch; Rachit M Vakil; Oscar Cingolani; Luigi Adamo
Journal:  Front Cardiovasc Med       Date:  2022-07-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.